Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Every three minutes, a child dies of tuberculosis (TB), even though treatment is available. In children, under-diagnosis is a major obstacle to effective treatment. New WHO recommendations, including treatment decision algorithms, could change all that. Photo Credit: Stuart Tibaweswa
Press release
Press release |
18 November 2025
Tuberculosis

MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB

5 min
Abu Al-Fadl, a young boy diagnosed early with tuberculosis, sits with his father and an MSF health promoter at Mustafa Al-Adhari Health Center in Sadr City. After completing his treatment, he has recovered and will soon return to school.. Photo Credit: Deniz Fahmi/MSF
Press release
Press release |
12 November 2025
Tuberculosis

MSF responds to WHO’s annual Global TB Report: Governments and donors must close the deadly gap in diagnosing and treating TB in children

3 min
Panel discussion in Brussels on how to improve the availability and affordability of TB medicines in the EU and EEA region. Shailly Gupta/MSF
Press release
Press release |
14 October 2025
Tuberculosis
Europe

MSF urges EU and EEA to put TB back on the health agenda

5 min
Mr and Ms Kimboi, both of whom are living with HIV, picking up their medicines at the MSF Chakpikarong clinic, Thailand, 2019 Photo credit: Jan-Joseph Stok
Press release
Press release |
26 September 2025
HIV/AIDS

MSF Supports $40 PrEP Access by 2027, Demands Broader Reach and more Ambition to End HIV Epidemic

3 min
Sidra is a 12 year old affected by diabetes type I. She was admitted to Médecins Sans Frontières’ clinic (MSF) in Shatila Camp, South Beirut, almost a year ago, where he is provided with insulin pens.
Press release
Press release |
05 September 2025
Diabetes

MSF responds to inclusion of rapid-acting insulin analogues and GLP-1s to WHO Essential Medicines List

2 min
MSF evaluates and screens homeless people in shelters in downtown São Paulo. Activities also include health promotion. Photograph by Diogo Galvão
Press release
Press release |
03 September 2025
Intellectual property and trade
Brazil

MSF warns that US trade pressure may interfere with access to medicines in Brazil

5 min
A child receives measles vaccine at the Musenyi refugee site. 8,500 refugee children aged 6 months to 14 years were targeted for the vaccination campaign at the Musenyi site. Photo Credit: Dorine Niyungeko/MSF
Press release
Press release |
26 June 2025
Vaccines

Following Gavi’s replenishment, MSF calls for vaccine access for children in humanitarian settings

2 min
A man holds antiretroviral drugs at an activist meeting in Soshanguve, a township outside of Pretoria, South Africa, on April 16, 2015. Copyright: Stefan Heunis
Press release
Press release |
15 May 2025
HIV/AIDS Tuberculosis
South AfricaUnited States of America

US funding cuts threaten 39 research sites in South Africa, putting scientific advancements and hard-won progress against TB and HIV at risk

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury